Dr. Steve Fu is a Partner of WRVI Capital — a technology venture fund established in 2019 focussed on accelerating the monetization and scaling of disruptive companies globally.
Dr. Steve Fu has built a career appreciably increasing corporate value through technology investments and incubation, M&A and restructuring.
Since January 2017, Dr. Steve Fu has been with Walden International as a partner in both the WRV venture fund and Walden PE fund.
Dr. Fu was the Chief Strategy Officer of Fairchild Semiconductors, a recognized leader of power and energy management solutions. Dr. Fu led Fairchild’s central R&D teams, new business incubation, partnerships, restructuring and acquisitions. Dr. Fu drove all phases of Fairchild’s merger process culminating in the acquisition by ON Semiconductor for $2.4 billion which closed September 2016. Fairchild saw close to 3x appreciation in stock value during his tenure .
Prior to joining Fairchild, Dr. Fu drove corporate strategy development of Maxim Integrated Products as well as VMware’s desktop virtualization business, a leading Enterprise software company. Dr. Fu’s work culminated in 10 successful acquisitions, which accelerated Maxim and VMware’s entries into fast-growing markets and significant stock price appreciation. Maxim and VMware experienced gains of close to 4x and 6x appreciation in stock value during his tenure.
During the last four years of Dr. Fu’s eleven-year career at Cisco, he developed and executed strategies for Cisco’s strategic semiconductor practice and emerging technology, consumer, and China investments. Steve’s work culminated in more than 15 minority investments, and 10 successful acquisitions.
Steve received his Ph.D. EE from Stanford University in 2001, BSEE from UC Berkeley and is a recipient of the President’s scholarship.